RGEN Repligen Corp

Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.

$262.44  -1.35 (-0.51%)
As of 10/19/2021 15:59:52 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  USA
IPO date:  03/05/2001
Outstanding shares:  54,904,466
Average volume:  439,847
Market cap:   $14,655,100,065
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    759916109
ISIN:        US7599161095
Valuation   (See tab for details)
PE ratio:   144.92
PB ratio:   9.05
PS ratio:   28.82
Return on equity:   6.23%
Net income %:   19.65%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy